Pancreatic Cancer Research

ResearcherNortheast Forestry UniversityNo recent work listed

Ze Yu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5849-3413; OpenAlex author ID A5060400019. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 2 papers · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper

Papers 5

  1. A SLC31A1-MEK-DNMT1-miR-124 feedback loop contributes to pancreatic cancer progression. Co-author DOI 10.1016/j.gendis.2022.05.033↗
  2. Molecular chaperone HspB2 inhibited pancreatic cancer cell proliferation via activating p53 downstream gene RPRM, BAI1, and TSAP6. Co-author DOI 10.1002/jcb.29455↗
  3. Zinc chelator TPEN induces pancreatic cancer cell death through causing oxidative stress and inhibiting cell autophagy. First author DOI 10.1002/jcp.28670↗
  4. Blockage of SLC31A1-dependent copper absorption increases pancreatic cancer cell autophagy to resist cell death. Co-author DOI 10.1111/cpr.12568↗
  5. Baicalein inhibits pancreatic cancer cell proliferation and invasion via suppression of NEDD9 expression and its downstream Akt and ERK signaling pathways. Co-author DOI 10.18632/oncotarget.16912↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chun‐Bo Teng · 5 shared papers, 2017–2023 · strength 0.57
  2. Yuzhe Nie · 4 shared papers, 2017–2023 · strength 0.47
  3. Sheng Tai · 3 shared papers, 2017–2023 · strength 0.35
  4. Jing Jin · 1 shared paper, 2023 · strength 0.18
  5. Rongtao Zhou · 2 shared papers, 2017–2019 · strength 0.17
  6. Zhen Yu · 1 shared paper, 2019 · strength 0.10
  7. Liang Jin · 1 shared paper, 2019 · strength 0.10
  8. Jin‐San Zhang · 1 shared paper, 2019 · strength 0.10
  9. Yi Pan · 1 shared paper, 2019 · strength 0.10
  10. Lin Yang · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.